Search
01/10/2025
ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study-Trial in Progress
Provencio, M, Aguiar, D, Antoñanzas, M, Areses, MC, Azkárate, A, Barba, A, Bernabé, R, Blanco, R, Borregon, M, Campos, B, Coves, J, De Castro, J, Domènech, M, Domine, M, Campelo, RG, Gozálvez, CL, Huidobro, G, Insa, A, Juan-Vidal, O, Castro, RL, Martínez-Marti, A, Medina, S, Moreno, MA, Nadal, E, Olivares, A, Reguart, N, Sala, MA, Medina, K, Vilà, L, Massuti, B. ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study-Trial in Progress. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025
Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study
Grohé, C, Wu, YL, Tsuboi, M, Majem, M, John, T, Bolanos, A, Taylor, R, Sandelin, M, Herbst, RS. Early Treatment Discontinuation of Osimertinib in the Adjuvant Setting: Insights From the ADAURA Study. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025
From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation
Villalobos, E, Mehra, P, Diaz-Manera, J. From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation. JOURNAL OF PHYSIOLOGY-LONDON. 2025; 603(19)DOI:10.1113/JP288924. PMID:40846464. IF:4.400(Q1/1D).
01/10/2025
INTERACTION OF PREVIOUS MAJOR ADVERSE CARDIOVASCULAR EVENTS, ANTITHROMBOTICS, AND STATINS ON OUTCOMES IN INTRACEREBRAL HEMORRHAGE
Prats-Sanchez, L, Lambea-Gil, A, Martí-Fàbregas, J, Ezcurra, G, Guasch, M, Fernandez-Vidal, JM, Renom, PC, Martínez-Domeño, A, Ramos-Pachón, A, Hic-Cat, I. INTERACTION OF PREVIOUS MAJOR ADVERSE CARDIOVASCULAR EVENTS, ANTITHROMBOTICS, AND STATINS ON OUTCOMES IN INTRACEREBRAL HEMORRHAGE. International Journal of Stroke. 2025; 20DOI:. PMID:. IF:8.700(Q1/1D).
01/10/2025
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study
Tolosa-Ridao, C, González, MB, Gómez, MA, Fox, L, Artigas, MDP, Santamaria, A, González, MDQ, Salinas, AS, Camacho, JMS, Alvaro, VI, Abdallahi-Lefdil, Z, Navascues, JC, Pardo, L, Fernández-Luis, S, Suárez, LPV, Villar, S, Beorlegui-Murillo, P, Esquirol, A, García, II, Ribes-Amorós, J, Lavilla, E, Lopez-Marín, J, Basalobre, P, Filaferro, S, Cedillo, A, Bento, L, Sureda, A, Salas, MQ. Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study. BRITISH JOURNAL OF HAEMATOLOGY. 2025; 207(4)DOI:10.1111/bjh.70068. PMID:40796522. IF:3.800(Q1/3D).
01/10/2025
The Barcelona injury surveillance system
Pérez, K, Santamariña-Rubio, E, Cortés-Albadalejo, M, Artazcoz, L, Hyder, AA, Kass, D, Borrell, C. The Barcelona injury surveillance system. EUROPEAN JOURNAL OF PUBLIC HEALTH. 2025; 35DOI:10.1093/eurpub/ckaf161.884. PMID:. IF:3.900(Q1/2D).
01/10/2025
Commentary on: Acute retinal necrosis associated with dimethyl fumarate
Vidal-Jordana, A. Commentary on: Acute retinal necrosis associated with dimethyl fumarate. Multiple Sclerosis Journal. 2025; 31(12)DOI:10.1177/13524585251326487. PMID:40320665. IF:5.000(Q1/2D).
01/10/2025
A Systematic Review of Outcomes of Redo Ureteroneocystostomy Subsequent to Kidney Transplantation in Pediatric Recipients
Haberal, HB, Marco, BB, Donmez, MI, Pecoraro, A, Piana, A, Prudhomme, T, López-Abad, A, Breda, A, Territo, A. A Systematic Review of Outcomes of Redo Ureteroneocystostomy Subsequent to Kidney Transplantation in Pediatric Recipients. INTERNATIONAL JOURNAL OF UROLOGY. 2025; 32(10)DOI:10.1111/iju.70148. PMID:40488818. IF:2.200(Q2/5D).